Corvus Pharmaceuticals
CRVS
CRVS
61 hedge funds and large institutions have $66.7M invested in Corvus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
6.97% less ownership
Funds ownership: 66.43% → 59.46% (-7%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
51% less capital invested
Capital invested by funds: $136M → $66.7M (-$69.7M)
Holders
61
Holding in Top 10
1
Calls
$552K
Puts
$536K
Top Buyers
| 1 | +$5.62M | |
| 2 | +$1.9M | |
| 3 | +$1.84M | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.27M |
| 5 |
Renaissance Technologies
New York
|
+$1.03M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$7.66M | |
| 3 | -$1.56M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$968K |
| 5 |
Jane Street
New York
|
-$842K |